Brainscope’s Handheld TBI Assessment Device Receives FDA Clearance

A new handheld device developed by the medical neurotechnology company Brainscope has obtained clearance from the U.S. Food and Drug Administration (FDA) as an adjunctive technology to Computerized Tomography (CT) scans for assessment of traumatic brain injury (TBI). The compact device, called Ahead 100, records the electroencephalograph (EEG) of patients, and can rapidly and accurately determines the severity of a head injury and the need for further assessment of injury via CT scan. The device is particularly useful in urgent care settings, immediate assessment of sports injuries, and limited resource settings. The next generation of this device is an improved technology that is also adaptable for use with smartphone and tables. EEG-based technologies hold promise for ALS patients, so hopefully ALS is also on their radar!

A new handheld device developed by the medical neurotechnology company Brainscope has obtained clearance from the U.S. Food and Drug Administration (FDA) as an adjunctive technology to Computerized Tomography (CT) scans for assessment of traumatic brain injury (TBI). The compact device, called Ahead 100, records the electroencephalograph (EEG) of patients, and can rapidly and accurately determines the severity of a head injury and the need for further assessment of injury via CT scan. The device is particularly useful in urgent care settings, immediate assessment of sports injuries, and limited resource settings. The next generation of this device is an improved technology that is also adaptable for use with smartphone and tables. EEG-based technologies hold promise for ALS patients, so hopefully ALS is also on their radar!

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail